查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1890430

全球伴侣动物药品市场评估：依物种、适应症、给药途径、通路、地区、机会和预测（2018-2032 年）

Global Companion Animal Pharmaceuticals Market Assessment, By Animal Type, By Indication, By Route of Administration, By Distribution Channel, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Markets & Data | 英文 244 Pages | 商品交期: 3-5个工作天内

价格

预计 2025 年至 2032 年，伴侣动物药品市场将以 9.15% 的复合年增长率增长，从 2024 年的 209.1 亿美元增长至 2032 年的 421.4 亿美元。市场成长的驱动因素包括：伴侣动物饲养量的增加、全球扶持政策的推出、可支配收入的成长、兽药投资的增加以及宠物保险的普及。

对兽医诊断解决方案技术创新投入的增加也推动了市场成长。先进诊断解决方案的引入能够早期发现各种疾病，使宠物主人能够有效地为宠物提供医疗和治疗干预。兽医技术的进步正在推动新型药物传输系统和标靶疗法的普及，从而改善疾病管理。对创新和研究的日益重视、对伴侣动物健康的日益关注以及宠物保险的日益普及，也推动了市场成长。

目录

第一章：专案范围与定义

第二章：研究方法

第三章：美国关税的影响

第四章：摘要整理

第五章：2018-2032年全球伴侣动物药品市场展望

  • 市场规模分析与预测
    • 以价值计算
  • 市占率分析与预测
    • 依动物种类计算物种
      • 犬类
      • 猫类
      • 马类
      • 其他
    • 依适应症
      • 传染病
      • 皮肤病
      • 寄生虫感染
      • 骨科疾病
      • 其他
    • 依给药途径
      • 口服
      • 注射
      • 外用
    • 依分销管道
      • 兽医院和诊所
      • 零售药局
      • 其他
    • 依地区
      • 北美
      • 欧洲
      • 亚太地区
      • 南美
      • 中东和非洲
    • 依公司划分的市占率分析
  • 市场地图分析，2024
    • 动物种类
    • 依适应症
    • 依给药途径
    • 依分销管道
    • 依地区

第六章 北美伴侣动物药品市场展望，2018-2032

  • 市场规模分析与预测
    • 依价值
  • 市占率分析与预测
    • 依动物种类
      • 犬
      • 猫
      • 马
      • 其他
    • 依适应症
      • 传染病
      • 皮肤病
      • 寄生虫感染
      • 骨科疾病
      • 其他
    • 依给药途径给药途径
      • 口服
      • 注射
      • 外用
    • 依分销管道
      • 兽医院和诊所
      • 零售药局
      • 其他
    • 依国家/地区划分的市场占有率
      • 美国
      • 加拿大
      • 墨西哥
  • 依国家/地区划分的市场评估
    • 美国伴侣动物药品市场展望，2018-2032
      • 市场规模分析及预测
      • 市占率分析及预测
    • 加拿大
    • 墨西哥

第七章 欧洲伴侣动物药品市场展望，2018-2032

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 土耳其
  • 波兰

第八章 亚太地区伴侣动物药品市场展望，2018-2032

  • 印度
  • 中国
  • 日本
  • 澳大利亚
  • 越南
  • 东南亚韩国
  • 印尼
  • 菲律宾

第九章：南美洲伴侣动物药品市场展望（2018-2032）

  • 巴西
  • 阿根廷

第十章：中东与非洲伴侣动物药品市场展望（2018-2032）

  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 南非

第十一章：供需分析

第十二章：价值链分析

第十三章：波特五力分析

第十四章：PESTLE分析

第十五章：市场领导者的 ESG 分析

第十六章：市场动态

  • 市场驱动因素
  • 市场挑战

第十七章：市场趋势与发展

  • 技术分析

第十八章：监理架构与创新

第十九章：个案研究

第二十章：竞争格局

  • 前五大竞赛矩阵
  • 前五大 SWOT 分析
  • 前十大关键参与者
    • 硕腾服务有限公司 (Zoetis Services LLC.)
      • 公司详情
      • 关键管理人员
      • 产品与服务
      • 财务资讯（已公布）
      • 主要市场趋势与地理扩张
      • 近期发展/合作/伙伴关係/併购
    • 默克公司
    • 勃林格殷格翰国际股份有限公司
    • 礼来动保
    • 维克
    • 西华
    • 维托奎诺
    • 德克拉製药股份有限公司
    • 奥利安集团控股有限公司
    • 新根公司

以上列出的公司排名不分先后，排名依据市场占有率而定，并可能根据研究过程中获得的资讯而有所变动。

第21章：策略建议

第22章：关于本研究公司及免责声明

Product Code: MX13877

Companion animal pharmaceuticals market is projected to witness a CAGR of 9.15% during the forecast period 2025-2032, growing from USD 20.91 billion in 2024 to USD 42.14 billion in 2032. The market's growth is supported by the increasing adoption of companion animals, the introduction of supportive initiatives and policies globally, rising disposable incomes, increasing investments in veterinary pharmaceuticals, and growing availability of pet insurance

The market's growth is also supported by the increasing investments in technological innovations in veterinary diagnostic solutions. The introduction of advanced diagnostic solutions ensures the timely detection of various diseases, allowing pet owners to seek medical attention and therapeutic intervention for their pets in a time-efficient manner. As veterinary technologies evolve, the delivery of novel drug delivery systems and targeted therapies is increasing, ensuring improved disease management. The rising emphasis on innovation and research activities, coupled with growing awareness about companion animal health and the broader availability of pet insurance, is also bolstering the market's expansion.

New Product Investments Drive Growth Opportunities in the Market

Increasing investments in new launches are providing lucrative growth opportunities for the market by ensuring the availability of convenient, effective, and innovative products that support the evolving requirements of veterinarians and pet owners. Such launches often include advanced formulations, such as oral tick and flea treatments, as well as specialized therapeutics that target infectious and chronic diseases in pets. Additionally, rapid innovations in nutraceuticals, personalized medicines, and drug delivery systems are improving efficacy and adherence, ensuring wider adoption and positively influencing the market's expansion. Thus, various companies globally are focusing on launching products that facilitate easy adherence.

For instance, in April 2024, Boehringer Ingelheim International GmbH launched NexGard SPECTRA in India, following the approval by the Central Drugs Standard Control Organization (CDSCO). The soft chew provides a comprehensive range of external and internal parasite control in a single dose, administered monthly. The prescription-only product contains milbemycin oxime, which controls intestinal worms and provides protection against heartworm, as well as afoxolaner, which targets ticks and fleas.

Increasing Pet Insurance Boosts Global Companion Animal Pharmaceuticals Market Growth

As more pet owners are purchasing pet insurance, the financial barriers to pharmaceutical products for companion animals are being eliminated, resulting in increased demand for therapeutic and preventive purposes. Insurance coverage includes reimbursement for prescription medications, wellness visits, and management of chronic and infectious diseases, increasing accessibility for pet owners to high-quality and specialized pharmaceutical solutions.

As per the North America Pet Health Insurance Association, in 2024, the United States experienced a 12.7% growth in the total number of pets insured compared to 2023. With insurance, pet owners are more likely to seek timely veterinary intervention and adhere to prescribed treatment regimens, directly boosting demand for pharmaceuticals. Additionally, as the emotional bonds between pet owners and their companion animals increase, they are more likely to focus on their health and well-being, resulting in them providing their companion animals with regular check-ups and treatment interventions, which provide lucrative growth opportunities for the market.

Veterinary Hospitals and Clinics Hold Major Market Share

The segment's dominance can be attributed to the presence of advanced healthcare infrastructure, skilled professionals, and a comprehensive range of treatments and services across veterinary hospitals and clinics. Additionally, these facilities are equipped with advanced laboratory capabilities, surgical equipment, and diagnostic tools, allowing them to provide precise diagnoses and effectively treat a wide range of conditions in companion animals. The presence of skilled veterinarians ensures that pets receive specialized care, including the administration of pharmaceuticals, vaccinations, and preventive medications tailored to the specific requirements of companion animals. Thus, governments worldwide are increasingly funding veterinary hospitals and clinics to ensure that the animal population receives optimal care.

For instance, in May 2025, Oklahoma State University received USD 250 million in state funding to build a new veterinary hospital. Such investments are strengthening clinical capabilities, veterinary education, and research infrastructure, thereby propelling the demand for companion animal pharmaceuticals and positively influencing the market's expansion.

North America Dominates the Global Companion Animal Pharmaceuticals Market Growth

The market's rapid expansion in North America can be attributed to the rising adoption of companion animals in the region, the strong presence of leading market players, and high awareness about veterinary care practices and treatments. As per the estimates of the American Society for the Prevention of Cruelty to Animals (ASPCA), 4.2 million shelter animals were adopted in the United States in 2024. Furthermore, the region's rising innovations in companion animal medicines in the region, driven by the strong presence of various research organizations and institutions focused on veterinary care, are also providing lucrative growth opportunities for the market. Additionally, increasing consumer awareness about pet surgeries and various treatment solutions, coupled with the rising availability of pet insurance, is further bolstering the demand for pharmaceutical products for companion animals. Pet insurance plays a crucial role in helping pet owners manage pharmaceutical costs and other essential expenses that are vital for ensuring the health and well-being of their companion animals.

Impact of the U.S. Tariff on the Global Companion Animal Pharmaceuticals Market

The recently imposed tariffs are causing unrest in supply chains as the companion animal pharmaceuticals market relies heavily on international channels for sourcing the necessary raw materials, including biologics and antigens. Additionally, the growing threat of retaliatory tariffs is expected to result in reduced profit margins for the manufacturers and lead to additional operational uncertainties.

To mitigate the impact of the tariff, leading market players are focusing on shifting their supplier base; however, this shift is triggering an increased requirement for new regulatory filings and approvals, causing further disruptions in the supply chain.

Key Players Landscape and Outlook

Key players in the market are launching new products and technologies, engaging in mergers and acquisitions to expand their product portfolios and geographical presence, and increasing their revenue.

For instance, in September 2024, Elanco received approval from the US FDA for Zenrelia, an effective, safe, and convenient oral JAK inhibitor for controlling atopic dermatitis and pruritus associated with allergic dermatitis in dogs that are 12 months or older.

Additionally, the key players of the market are also engaging in mergers and acquisitions to support innovations in pet therapeutics. For instance, in January 2024, Ceva acquired Scout Bio, Inc., enhanced its biotechnology activities and developed preventive and biological medicines. Such acquisitions are also expected to bolster the development and availability of biotherapeutics for companion animals.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Companion Animal Pharmaceuticals Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Animal Type
      • 5.2.1.1. Dogs
      • 5.2.1.2. Cats
      • 5.2.1.3. Horses
      • 5.2.1.4. Others
    • 5.2.2. By Indication
      • 5.2.2.1. Infectious Disease
      • 5.2.2.2. Dermatologic Disease
      • 5.2.2.3. Parasitic Infection
      • 5.2.2.4. Orthopedic Disease
      • 5.2.2.5. Others
    • 5.2.3. By Route of Administration
      • 5.2.3.1. Oral
      • 5.2.3.2. Injectable
      • 5.2.3.3. Topical
    • 5.2.4. By Distribution Channel
      • 5.2.4.1. Veterinary Hospitals and Clinics
      • 5.2.4.2. Retail Pharmacies
      • 5.2.4.3. Others
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia-Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East and Africa
    • 5.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Animal Type
    • 5.3.2. By Indication
    • 5.3.3. By Route of Administration
    • 5.3.4. By Distribution Channel
    • 5.3.5. By Region

6. North America Companion Animal Pharmaceuticals Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Animal Type
      • 6.2.1.1. Dogs
      • 6.2.1.2. Cats
      • 6.2.1.3. Horses
      • 6.2.1.4. Others
    • 6.2.2. By Indication
      • 6.2.2.1. Infectious Disease
      • 6.2.2.2. Dermatologic Disease
      • 6.2.2.3. Parasitic Infection
      • 6.2.2.4. Orthopedic Disease
      • 6.2.2.5. Others
    • 6.2.3. By Route of Administration
      • 6.2.3.1. Oral
      • 6.2.3.2. Injectable
      • 6.2.3.3. Topical
    • 6.2.4. By Distribution Channel
      • 6.2.4.1. Veterinary Hospitals and Clinics
      • 6.2.4.2. Retail Pharmacies
      • 6.2.4.3. Others
    • 6.2.5. By Country Share
      • 6.2.5.1. The United States
      • 6.2.5.2. Canada
      • 6.2.5.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Companion Animal Pharmaceuticals Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Animal Type
          • 6.3.1.2.1.1. Dogs
          • 6.3.1.2.1.2. Cats
          • 6.3.1.2.1.3. Horses
          • 6.3.1.2.1.4. Others
        • 6.3.1.2.2. By Indication
          • 6.3.1.2.2.1. Infectious Disease
          • 6.3.1.2.2.2. Dermatologic Disease
          • 6.3.1.2.2.3. Parasitic Infection
          • 6.3.1.2.2.4. Orthopedic Disease
          • 6.3.1.2.2.5. Others
        • 6.3.1.2.3. By Route of Administration
          • 6.3.1.2.3.1. Oral
          • 6.3.1.2.3.2. Injectable
          • 6.3.1.2.3.3. Topical
        • 6.3.1.2.4. By Distribution Channel
          • 6.3.1.2.4.1. Veterinary Hospitals and Clinics
          • 6.3.1.2.4.2. Retail Pharmacies
          • 6.3.1.2.4.3. Others
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Companion Animal Pharmaceuticals Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Companion Animal Pharmaceuticals Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Companion Animal Pharmaceuticals Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Companion Animal Pharmaceuticals Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. ESG Analysis of Market Leaders

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

  • 17.1. Technology Analysis

18. Regulatory Framework and Innovation

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Zoetis Services LLC.
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 20.3.2. Merck & Co., Inc.
    • 20.3.3. Boehringer Ingelheim International GmbH
    • 20.3.4. Elanco
    • 20.3.5. Virbac
    • 20.3.6. Ceva
    • 20.3.7. Vetoquinol
    • 20.3.8. Dechra Pharmaceuticals PLC
    • 20.3.9. Orion Group Holdings, Inc.
    • 20.3.10. Neogen Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 3. Global Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 4. Global Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 5. Global Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 6. Global Companion Animal Pharmaceuticals Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 9. North America Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 10. North America Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 11. North America Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 12. North America Companion Animal Pharmaceuticals Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 15. United States Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 16. United States Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 17. United States Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 18. Canada Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 20. Canada Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 21. Canada Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 22. Canada Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 23. Mexico Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 25. Mexico Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 26. Mexico Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 27. Mexico Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 28. Europe Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 30. Europe Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 31. Europe Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 32. Europe Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 33. Europe Companion Animal Pharmaceuticals Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 36. Germany Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 37. Germany Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 38. Germany Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 39. France Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 41. France Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 42. France Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 43. France Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 44. Italy Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 46. Italy Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 47. Italy Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 48. Italy Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 49. United Kingdom Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 51. United Kingdom Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 52. United Kingdom Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 53. United Kingdom Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 54. Russia Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 56. Russia Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 57. Russia Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 58. Russia Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 59. Netherlands Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 61. Netherlands Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 62. Netherlands Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 63. Netherlands Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 64. Spain Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 66. Spain Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 67. Spain Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 68. Spain Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 69. Turkey Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 71. Turkey Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 72. Turkey Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 73. Turkey Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 74. Poland Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 76. Poland Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 77. Poland Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 78. Poland Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 79. Asia-Pacific Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. Asia-Pacific Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 81. Asia-Pacific Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 82. Asia-Pacific Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 83. Asia-Pacific Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 84. Asia-Pacific Companion Animal Pharmaceuticals Market Share (%), By Country, 2018-2032F
  • Figure 85. India Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. India Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 87. India Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 88. India Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 89. India Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 90. China Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. China Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 92. China Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 93. China Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 94. China Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 95. Japan Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Japan Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 97. Japan Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 98. Japan Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 99. Japan Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 100. Australia Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 101. Australia Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 102. Australia Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 103. Australia Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 104. Australia Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 105. Vietnam Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 106. Vietnam Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 107. Vietnam Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 108. Vietnam Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 109. Vietnam Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 110. South Korea Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 111. South Korea Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 112. South Korea Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 113. South Korea Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 114. South Korea Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 115. Indonesia Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 116. Indonesia Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 117. Indonesia Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 118. Indonesia Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 119. Indonesia Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 120. Philippines Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 121. Philippines Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 122. Philippines Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 123. Philippines Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 124. Philippines Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 125. South America Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 126. South America Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 127. South America Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 128. South America Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 129. South America Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 130. South America Companion Animal Pharmaceuticals Market Share (%), By Country, 2018-2032F
  • Figure 131. Brazil Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Brazil Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 133. Brazil Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 134. Brazil Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 135. Brazil Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 136. Argentina Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Argentina Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 138. Argentina Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 139. Argentina Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 140. Argentina Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 141. Middle East & Africa Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 143. Middle East & Africa Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 144. Middle East & Africa Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 145. Middle East & Africa Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 146. Middle East & Africa Companion Animal Pharmaceuticals Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 149. Saudi Arabia Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 150. Saudi Arabia Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 151. Saudi Arabia Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 152. UAE Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 154. UAE Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 155. UAE Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 156. UAE Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 157. South Africa Companion Animal Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Companion Animal Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 159. South Africa Companion Animal Pharmaceuticals Market Share (%), By Indication, 2018-2032F
  • Figure 160. South Africa Companion Animal Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 161. South Africa Companion Animal Pharmaceuticals Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 162. By Animal Type Map - Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Indication Map - Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Route of Administration Map - Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By Distribution Channel Map - Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map - Market Size (USD Billion) & Growth Rate (%), 2024